WC Walker & Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$3.41M Buy
31,258
+89
+0.3% +$9.1K 1.81% 13
2022
Q3
$3.07M Buy
31,169
+179
+0.6% +$16K 1.74% 16
2022
Q2
$2.94M Sell
30,990
-165
-0.5% -$14.6K 1.73% 15
2022
Q1
$2.68M Buy
31,155
+402
+1% +$31.7K 1.39% 24
2021
Q4
$2.5M Buy
30,753
+1,220
+4% +$97.2K 1.24% 28
2021
Q3
$2.22M Buy
29,533
+973
+3% +$74K 1.19% 32
2021
Q2
$2.25M Buy
28,560
+420
+1% +$31.2K 1.18% 31
2021
Q1
$2.04M Buy
28,140
+489
+2% +$36.1K 1.15% 35
2020
Q4
$1.96M Buy
+27,651
New +$2.11M 1.13% 35

Other funds holding MRK

WC Walker & Associates's MRK Position: Q4 2022 in Review

WC Walker & Associates increased its Merck (MRK) stake by 0.29% in Q4 2022, buying an estimated $9.1K and bringing the position to 31,258 shares worth $3.41M. The position accounts for 1.81% of the portfolio, ranked #13.

WC Walker & Associates first reported a position in MRK in Q4 2020 and has held it in 9 quarters since. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • WC Walker & Associates held 31,258 shares of Merck worth $3.41M as of Q4 2022.
  • WC Walker & Associates bought 89 Merck shares in Q4 2022, an estimated $9.1K.
  • Merck made up 1.81% of WC Walker & Associates's portfolio in Q4 2022, its #13 holding.
  • WC Walker & Associates first reported a position in Merck in Q4 2020 and has held it in 9 quarters since.
  • 3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on WC Walker & Associates's 13F filing for Q4 2022, filed 23 Feb 2023.